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Introduction:
Background:
• Osteoporosis is a significant burden for our aging population. Developing a better understanding of the 
genetic underpinnings of poor bone quality may assist in the future development of prevention strategies.
• Correa-Rodriguez et al. have identified a group of single nucleotide polymorphisms (SNPs) that were 
associated with both body composition and bone mineral density (BMD) in a population of Spanish 
Caucasians.3 In particular, they found that SNP rs3736228 in the low-density lipoprotein receptor related 
protein 5 (LRP5) gene had an influence on BMD.1,2,3
• While the role of LRP5 in the Wnt canonical pathway in regulating osteoblast growth and inhibiting apoptosis 
has been fairly well characterized, its association with phenotypic BMD and osteoporosis has only been 
explored in a limited fashion.4
Objective:
• The aim of this study is to expand existing knowledge of LRP5 and explore the association of rs3736228 
polymorphisms and BMD to replicate the findings of previous studies in a cohort of healthy young adults.
Methods:
Study Cohorts:
• Assessing Inherited Markers of Metabolic Syndrome in the Young (AIMMY)
• Healthy Caucasian young adults (Males: n=93,, Females: n=96, age range: 18-35 years)
• Paticipants were recruited to identify genetic variants associated with risk factors for metabolic syndrome
Phenotyping:
• Applied Biosystems Taqman allelic discrimination assays and the Applied Biosystems 7900HT Real-Time PCR 
were utilized to genotype the DNA samples in the AIMMY cohort per manufacturer’s instructions. 
Data Analysis:
• Hardy-Weinberg Equilibrium was assessed for LRP5  SNP rs3736228.
• Data was stratified by sex and run through analysis of covariance (ANCOVA).
• Where the f-tests were significant, post hoc pair-wise comparisons were performed and the p-values were 
adjusted for multiple comparison using the Sidak method.
Results:
• The genotype distribution for SNP rs3736228 in the AIMMY cohort was found to be in HWE. (See Figure 2)
• Using a dominant model, we found that females with one or more copies of the risk T allele of SNP rs3736228 
had a significant negative association with total BMD (p = 0.0347). (See Figure 4)
• However, a similar association was not seen in males in this cohort. 
• We did not find a significant association for this polymorphism and height, weight, or BMI.
Result (continued):
Discussion & Significance:
References:
• The rs3736228 CC variant of the LRP5 gene was found to be associated with BMD in females in the AIMMY 
cohort. The more common C allele encodes alanine, while the rarer T allele encodes valine. The LRP5 gene has 
now been shown in multiple studies to be associated with bone quality measures like calcaneal Qualitative 
Ultrasound (QUS) and BMD. 
• Our study has expanded these findings and suggests that SNP rs3736228 also influences BMD in healthy young 
females. This supports the work of Correa-Rodriguez et al that found that when stratifying by sex, females only 
showed a trend towards significance (p = 0.092) in QUS measures.1
• While the development of BMD is polygenic, our work suggests that focus on LRP5 polymorphisms may be 
particularly helpful in defining genetic risk for low BMD. In addition, given that this polymorphism has shown to 
have pleiotropic effects, we plan to investigate the associations of SNP rs3736228 with other anthropomorphic 
phenotypes.
• This study expands our understanding of the importance of LRP5 rs3736228 polymorphisms in BMD by 
extending its relationship to a cohort of predominantly Caucasian college students. While the development of 
BMD is polygenic, this work broadened the role of SNP rs3736228 across the age span and underscores the 
sexual dimorphism seen in musculoskeletal traits. 
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Figure 1: AIMMY Demographics
Figure 3: Phenotypes Run in AIMMY
Figure 4: Significant Associations Found in AIMMY
Figure 5: Plot of SNP Variations vs. Total BMD
Characteristic
Females Males
N Mean ± SD N Mean ± SD
Age (years) 96 22.3 ± 4.4 93 23.7 ± 4.2
Weight (kg) 96 62.4 ± 9.2 93 78.0 ± 12.3
Height (cm) 96 165.9 ± 5.8 93 178.8 ± 7.7
BMI 96 22.7 ± 2.9 93 24.3 ± 3.1
Figure 2: Hardy-Weinberg Equilibrium Calculations
Genotyping:
• Height, weight, BMI, and total BMD.
• Phenotypes were adjusted for age, except for total BMD which was adjusted for both age and height.
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SNP Phenotype Gender N; Adjusted mean ± SEM Significantly different genotypes
LRP5 
(rs3736228)
Total BMD Female
CC (N=57; 1.129 ± 0.011)*
CT/TT (N=27; 1.085 ±
0.016)*
*p=0.0327
P(C allele) P(T allele) HWE p-value
NCBI ExAC 5 0.8608 0.1392 -
AIMMY Cohort 0.841 0.159 0.50
Covariates used LRP5 (rs3736228)
Height Age X
Weight Age X
Total BMD Age, height X
BMI Age X
